Lantheus Holdings (LNTH) Interest Coverage Ratio: History & Chart

Lantheus Holdings, Inc.(LNTH)

Drug Manufacturers - Specialty & Generic · Bedford, MA

$99.91-0.28 (-0.28%)

Delayed quote: Oct 6, 2026, 1:30 PM EDT

About Lantheus Holdings, Inc.

Lantheus Holdings, Inc. is a global pharmaceutical company dedicated to the development, manufacturing, and commercialization of advanced diagnostic and therapeutic agents. Their mission is to empower clinicians worldwide in the accurate diagnosis and effective treatment of a wide spectrum of conditions, particularly heart disease, various cancers, and other serious illnesses. Their current diagnostic portfolio features several key products: DEFINITY, a microbubble ultrasound contrast agent for cardiac evaluations; TechneLite, a technetium generator essential for nuclear medicine; Xenon-133, used to assess pulmonary function; Neurolite, which helps identify stroke-damaged areas in the brain; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 for detecting cardiovascular disease; and Gallium-67, utilized in identifying infections and cancerous tumors. They also offer the Automated Bone Scan Index, a tool for quantifying prostate cancer burden from bone scans; PYLARIFY, designed for visualizing lymph nodes, bone, and soft tissue metastases to detect recurrent or metastatic prostate cancer; and Cobalt (Co 57), a non-pharmaceutical radiochemical. In the therapeutic space, Lantheus provides AZEDRA, a radiopharmaceutical treatment for both adult and pediatric patients, and RELISTOR, a medication addressing opioid-induced constipation. The company's robust development pipeline includes promising innovations such as flurpiridaz F 18, an agent for assessing myocardial blood flow; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in both children and adults; PYLARIFY AI, an AI-powered medical device software for standardized quantitative analysis of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. Lantheus serves a diverse client base, including radiopharmacies, distributors, integrated delivery networks, hospitals, clinics, and group medical practices. They foster strategic collaborations with notable industry partners such as NanoMab Technology Limited, Bausch Health Companies, Inc., GE Healthcare Limited, Curium, Bayer AG, CytoDyn Inc., ROTOP, FUJIFILM, Regeneron Pharmaceuticals, Inc., and POINT Biopharma US Inc. Established in 1956, Lantheus Holdings, Inc. maintains its corporate headquarters in North Billerica, Massachusetts.

Bedford, MA

1,193 employees

www.lantheus.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mary Anne Heino

View full financials

LNTH Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

15.74x

INTEREST COVERAGE RATIO AVG TTM

15.80x

INTEREST COVERAGE RATIO AVG 3Y

21.48x

INTEREST COVERAGE RATIO AVG 5Y

17.99x

INTEREST COVERAGE RATIO AVG 10Y

9.07x

INTEREST COVERAGE RATIO AVG 15Y

N/A

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-0.39%

CURRENT VS 3Y AVG

-26.72%

CURRENT VS 5Y AVG

-12.50%

CURRENT VS 10Y AVG

+73.63%

CURRENT VS 15Y AVG

N/A

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-6.22x

median of 504 covered companies

CURRENT VS SECTOR MEDIAN

+352.85%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Lantheus Holdings, Inc. (LNTH)	$6.50B	15.74x	15.80x	21.48x	17.99x
Hims & Hers Health, Inc. (HIMS)vs ›	$6.52B	N/A	N/A	N/A	N/A
Immunovant, Inc. (IMVT)vs ›	$6.49B	N/A	N/A	N/A	N/A
Amneal Pharmaceuticals, Inc. (AMRX)vs ›	$6.48B	1.75x	1.35x	1.23x	1.08x
Chemed Corporation (CHE)vs ›	$6.66B	193.28x	199.58x	145.92x	155.47x
Rhythm Pharmaceuticals, Inc. (RYTM)vs ›	$6.19B	-9.33x	N/A	N/A	N/A
Alkermes plc (ALKS)vs ›	$6.95B	20.69x	19.66x	19.10x	16.50x
GRAIL Inc. (GRAL)vs ›	$5.99B	N/A	N/A	N/A	N/A
Iovance Biotherapeutics, Inc. (IOVA)vs ›	$5.90B	N/A	N/A	N/A	N/A
Ligand Pharmaceuticals Incorporated (LGND)vs ›	$5.89B	10.01x	10.01x	9.97x	7.31x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Lantheus Holdings, Inc. (LNTH)

$6.50B

15.74x

15.80x

21.48x

17.99x

Hims & Hers Health, Inc. (HIMS)vs ›

$6.52B

N/A

Immunovant, Inc. (IMVT)vs ›

$6.49B

N/A

Amneal Pharmaceuticals, Inc. (AMRX)vs ›

$6.48B

1.75x

1.35x

1.23x

1.08x

Chemed Corporation (CHE)vs ›

$6.66B

193.28x

199.58x

145.92x

155.47x

Rhythm Pharmaceuticals, Inc. (RYTM)vs ›

$6.19B

-9.33x

N/A

Alkermes plc (ALKS)vs ›

$6.95B

20.69x

19.66x

19.10x

16.50x

GRAIL Inc. (GRAL)vs ›

$5.99B

N/A

Iovance Biotherapeutics, Inc. (IOVA)vs ›

$5.90B

N/A

Ligand Pharmaceuticals Incorporated (LGND)vs ›

$5.89B

10.01x

9.97x

7.31x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Lantheus Holdings, Inc. (LNTH)?

The interest coverage ratio for LNTH stock is 15.74x.

Is Lantheus Holdings, Inc.'s interest coverage ratio high or low?

The interest coverage ratio of 15.74x is 13% below its 5-year average of 17.99x, around the middle of its 5-year range (-66.52x–52.73x).

What is the TTM average interest coverage ratio for Lantheus Holdings, Inc. (LNTH)?

The TTM average interest coverage ratio for LNTH stock is 15.80x.

What is the 3Y average interest coverage ratio for Lantheus Holdings, Inc. (LNTH)?

The 3Y average interest coverage ratio for LNTH stock is 21.48x.

What is the 5Y average interest coverage ratio for Lantheus Holdings, Inc. (LNTH)?

The 5Y average interest coverage ratio for LNTH stock is 17.99x.

What is the 10Y average interest coverage ratio for Lantheus Holdings, Inc. (LNTH)?

The 10Y average interest coverage ratio for LNTH stock is 9.07x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	20.39x
2026-03-31	16.72x
2025-12-31	15.20x
2025-09-30	8.81x
2025-06-30	17.89x
2025-03-31	21.25x
2024-12-31	22.57x
2024-09-30	27.28x
2024-06-30	21.13x
2024-03-31	20.66x
2023-12-31	27.27x
2023-09-30	22.23x
2023-06-30	25.17x
2023-03-31	-1.87x
2022-12-31	-66.52x
2022-09-30	52.73x
2022-06-30	43.03x
2022-03-31	39.05x
2021-12-31	-23.13x
2021-09-30	-9.13x
2021-06-30	-13.83x
2021-03-31	5.75x
2020-12-31	-0.19x
2020-09-30	-1.87x
2020-06-30	-2.90x
2020-03-31	3.66x
2019-12-31	5.85x
2019-09-30	3.62x
2019-06-30	3.20x
2019-03-31	3.52x
2018-12-31	3.67x
2018-09-30	3.71x
2018-06-30	3.71x
2018-03-31	3.74x
2017-12-31	2.16x
2017-09-30	2.89x
2017-06-30	4.18x
2017-03-31	2.20x
2016-12-31	2.09x
2016-09-30	1.86x
2016-06-30	2.03x
2016-03-31	2.52x
2015-12-31	1.75x
2015-09-30	1.89x
2015-06-30	0.39x
2015-03-31	1.07x
2014-12-31	1.11x
2014-09-30	0.87x
2014-06-30	0.94x
2014-03-31	0.80x
2013-12-31	-0.13x
2013-09-30	-0.41x
2013-06-30	-0.35x
2013-03-31	-0.86x

DATE

INTEREST COVERAGE RATIO

2026-06-30

20.39x

2026-03-31

16.72x

2025-12-31

15.20x

2025-09-30

8.81x

2025-06-30

17.89x

2025-03-31

21.25x

2024-12-31

22.57x

2024-09-30

27.28x

2024-06-30

21.13x

2024-03-31

20.66x

2023-12-31

27.27x

2023-09-30

22.23x

2023-06-30

25.17x

2023-03-31

-1.87x

2022-12-31

-66.52x

2022-09-30

52.73x

2022-06-30

43.03x

2022-03-31

39.05x

2021-12-31

-23.13x

2021-09-30

-9.13x

2021-06-30

-13.83x

2021-03-31

5.75x

2020-12-31

-0.19x

2020-09-30

-1.87x

2020-06-30

-2.90x

2020-03-31

3.66x

2019-12-31

5.85x

2019-09-30

3.62x

2019-06-30

3.20x

2019-03-31

3.52x

2018-12-31

3.67x

2018-09-30

3.71x

2018-06-30

3.71x

2018-03-31

3.74x

2017-12-31

2.16x

2017-09-30

2.89x

2017-06-30

4.18x

2017-03-31

2.20x

2016-12-31

2.09x

2016-09-30

1.86x

2016-06-30

2.03x

2016-03-31

2.52x

2015-12-31

1.75x

2015-09-30

1.89x

2015-06-30

0.39x

2015-03-31

1.07x

2014-12-31

1.11x

2014-09-30

0.87x

2014-06-30

0.94x

2014-03-31

0.80x

2013-12-31

-0.13x

2013-09-30

-0.41x

2013-06-30

-0.35x

2013-03-31

-0.86x

Interest Coverage Ratio: 15.74x

LNTH Interest Coverage Ratio

LNTH Average Interest Coverage Ratio Chart

LNTH Current vs Average Interest Coverage Ratio Chart

LNTH Interest Coverage Ratio Metrics

LNTH Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

LNTH Interest Coverage Ratio History

Related Metrics